Outpatient Antibiotic Use in Europe and Association with Resistance. Address for correspondence: Prof. Dr. H. Goossens Department of Microbiology, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium Tel (+) Fax (+) Herman Goossens, M.D., Ph.D., Matus Ferech, Pharm.D., Robert Vander Stichele, M.D.,, Monique Elseviers, Ph.D, and the ESAC Project Group. From the ESAC Management Team, Department of Microbiology, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium The LANCET Volume 365, Number February 2005

Figure 1 Total Outpatient antibiotic use in 26 European countries in 2002

Figure 2 Seasonal variation of total outpatient antibiotic use in 10 European countries

Figure 3 Outpatient use of penicillins (J01C) in 26 European countries in 2002 in descending order of narrow spectrum penicillins

Figure 5 Outpatient use of the third generation Cephalosporins in 2002

Figure 6 Outpatient use of Macrolides, Lincosamides and Streptogramins (J01F) in 26 European countries in 2002

Figure 7 Outpatient use of Quinolones (J01M) in 26 European countries in 2002